{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:28:49Z","timestamp":1792715329569,"version":"4.5.0"},"reference-count":162,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,8,20]]},"DOI":"10.1001\/jama.2019.8430","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T15:30:50Z","timestamp":1566315050000},"page":"666","source":"Crossref","is-referenced-by-count":147,"title":["Risk Assessment, Genetic Counseling, and Genetic Testing for<i>BRCA-<\/i>Related Cancer in Women"],"prefix":"10.1001","volume":"322","author":[{"given":"Heidi D.","family":"Nelson","sequence":"first","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Pappas","sequence":"additional","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Cantor","sequence":"additional","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Haney","sequence":"additional","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Holmes","sequence":"additional","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"jus190011r1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/00005792-199805000-00006","article-title":"Breast cancer susceptibility genes: BRCA1 and BRCA2.","volume":"77","author":"Brody","year":"1998","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"jus190011r2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"issue":"5182","key":"jus190011r3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"issue":"23","key":"jus190011r4","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1056\/NEJMra012284","article-title":"Breast and ovarian cancer.","volume":"348","author":"Wooster","year":"2003","journal-title":"N Engl J Med"},{"issue":"29","key":"jus190011r5","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","article-title":"Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.","volume":"32","author":"Sherman","year":"2014","journal-title":"J Clin Oncol"},{"issue":"22","key":"jus190011r6","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1002\/cncr.25439","article-title":"The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.","volume":"116","author":"Norquist","year":"2010","journal-title":"Cancer"},{"issue":"10","key":"jus190011r7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1054\/bjoc.2000.1407","article-title":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases.","volume":"83","author":"Anglian Breast Cancer Study Group","year":"2000","journal-title":"Br J Cancer"},{"issue":"2","key":"jus190011r8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/(ISSN)1098-2272","article-title":"Risk models for familial ovarian and breast cancer.","volume":"18","author":"Antoniou","year":"2000","journal-title":"Genet Epidemiol"},{"issue":"1","key":"jus190011r9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","article-title":"A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.","volume":"86","author":"Antoniou","year":"2002","journal-title":"Br J Cancer"},{"issue":"11","key":"jus190011r10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","article-title":"Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.","volume":"91","author":"Peto","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"jus190011r11","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.2078.13.12","article-title":"Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic whites.","volume":"13","author":"Whittemore","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"jus190011r12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ng0596-126","article-title":"Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.","volume":"13","author":"Neuhausen","year":"1996","journal-title":"Nat Genet"},{"issue":"20","key":"jus190011r13","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"jus190011r14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.","volume":"14","author":"Roa","year":"1996","journal-title":"Nat Genet"},{"issue":"5","key":"jus190011r15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies.","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"11","key":"jus190011r16","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance.","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"7","key":"jus190011r17","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-1029-3","article-title":"Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.","volume":"10","author":"Lakhani","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"4","key":"jus190011r18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1399-0004.2008.00974.x","article-title":"Probability of BRCA1\/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.","volume":"73","author":"Evans","year":"2008","journal-title":"Clin Genet"},{"issue":"4","key":"jus190011r19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10689-007-9152-x","article-title":"A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families.","volume":"6","author":"Tonin","year":"2007","journal-title":"Fam Cancer"},{"issue":"1","key":"jus190011r20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"issue":"4","key":"jus190011r21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA"},{"issue":"22","key":"jus190011r22","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1200\/JCO.2003.04.131","article-title":"Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.","volume":"21","author":"Levine","year":"2003","journal-title":"J Clin Oncol"},{"issue":"1","key":"jus190011r23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","article-title":"Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA).","volume":"21","author":"Mavaddat","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"jus190011r25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"issue":"4","key":"jus190011r28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"issue":"14","key":"jus190011r30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1093\/jnci\/90.14.1039","volume":"90","author":"Lindor","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"jus190011r32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast and ovarian, version 2.2017.","volume":"15","author":"Daly","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"jus190011r33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ajog.2015.03.003","article-title":"Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.","volume":"213","author":"Stuckey","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"23","key":"jus190011r34","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk.","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"jus190011r37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/M13-1684","article-title":"Risk assessment, gentic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S.Preventive Services Task Force recommendation.","volume":"160","author":"Nelson","year":"2014","journal-title":"Ann Intern Med"},{"issue":"7","key":"jus190011r38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/jmg.2007.056556","article-title":"Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.","volume":"45","author":"Antoniou","year":"2008","journal-title":"J Med Genet"},{"key":"jus190011r39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/1471-2407-9-283","article-title":"Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.","volume":"9","author":"Ashton-Prolla","year":"2009","journal-title":"BMC Cancer"},{"issue":"3","key":"jus190011r40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1200\/JCO.2005.02.2368","article-title":"Assessing BRCA carrier probabilities in extended families.","volume":"24","author":"Barcenas","year":"2006","journal-title":"J Clin Oncol"},{"issue":"11","key":"jus190011r41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/GIM.0b013e3181b9b04a","article-title":"Evaluation of a breast\/ovarian cancer genetics referral screening tool in a mammography population.","volume":"11","author":"Bellcross","year":"2009","journal-title":"Genet Med"},{"issue":"2","key":"jus190011r42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10549-016-3686-2","article-title":"A two-stage approach to genetic risk assessment in primary care.","volume":"155","author":"Biswas","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"jus190011r43","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/jmg.2003.017996","article-title":"A new scoring system for the chances of identifying a BRCA1\/2 mutation outperforms existing models including BRCAPRO.","volume":"41","author":"Evans","year":"2004","journal-title":"J Med Genet"},{"issue":"6","key":"jus190011r44","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/jmedgenet-2012-101415","article-title":"Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1\/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.","volume":"50","author":"Fischer","year":"2013","journal-title":"J Med Genet"},{"issue":"4","key":"jus190011r45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1034\/j.1399-0004.2000.580408.x","article-title":"A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center.","volume":"58","author":"Gilpin","year":"2000","journal-title":"Clin Genet"},{"issue":"8","key":"jus190011r46","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.","volume":"107","author":"Hoskins","year":"2006","journal-title":"Cancer"},{"issue":"10","key":"jus190011r47","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1002\/ijc.28875","article-title":"Validation of the Manchester scoring system for predicting BRCA1\/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer.","volume":"135","author":"Kast","year":"2014","journal-title":"Int J Cancer"},{"issue":"4","key":"jus190011r48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1399-0004.2006.00673.x","article-title":"Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and\/or ovarian cancer families of French Canadian descent.","volume":"70","author":"Oros","year":"2006","journal-title":"Clin Genet"},{"key":"jus190011r49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2350-9-116","article-title":"Selecting a BRCA risk assessment model for use in a familial cancer clinic.","volume":"9","author":"Panchal","year":"2008","journal-title":"BMC Med Genet"},{"issue":"7","key":"jus190011r50","doi-asserted-by":"publisher","first-page":"441","DOI":"10.7326\/0003-4819-147-7-200710020-00002","article-title":"Validity of models for predicting BRCA1 and BRCA2 mutations.","volume":"147","author":"Parmigiani","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"jus190011r51","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1245\/s10434-009-0697-9","article-title":"Validation of the pedigree assessment tool (PAT) in families with BRCA1 and BRCA2 mutations.","volume":"17","author":"Teller","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"jus190011r52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10897-015-9869-x","article-title":"Counselees\u2019 expressed level of understanding of the risk estimate and surveillance recommendation are not associated with breast cancer surveillance adherence.","volume":"25","author":"Albada","year":"2016","journal-title":"J Genet Couns"},{"issue":"14","key":"jus190011r53","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.293.14.1729","article-title":"Racial differences in the use of BRCA1\/2 testing among women with a family history of breast or ovarian cancer.","volume":"293","author":"Armstrong","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"jus190011r54","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10897-007-9136-x","article-title":"Psychological factors associated with emotional responses to receiving genetic risk information.","volume":"17","author":"Bennett","year":"2008","journal-title":"J Genet Couns"},{"issue":"2","key":"jus190011r55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10689-008-9221-9","article-title":"Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment","volume":"8","author":"Bennett","year":"2009","journal-title":"Fam Cancer"},{"issue":"5","key":"jus190011r56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ypmed.2006.07.002","article-title":"Effects of a telephone counseling intervention on sisters of young women with breast cancer.","volume":"43","author":"Bloom","year":"2006","journal-title":"Prev Med"},{"issue":"1","key":"jus190011r57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1037\/1099-9809.12.1.45","article-title":"Effects of counseling Ashkenazi Jewish women about breast cancer risk.","volume":"12","author":"Bowen","year":"2006","journal-title":"Cultur Divers Ethnic Minor Psychol"},{"issue":"1","key":"jus190011r58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0738-3991(03)00122-8","article-title":"Breast cancer risk counseling improves women\u2019s functioning.","volume":"53","author":"Bowen","year":"2004","journal-title":"Patient Educ Couns"},{"issue":"5","key":"jus190011r59","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00125817-200209000-00007","article-title":"Effects of risk counseling on interest in breast cancer genetic testing for lower risk women.","volume":"4","author":"Bowen","year":"2002","journal-title":"Genet Med"},{"issue":"2","key":"jus190011r60","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.bjc.6600051","article-title":"A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk.","volume":"86","author":"Brain","year":"2002","journal-title":"Br J Cancer"},{"issue":"9","key":"jus190011r61","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/pon.1807","article-title":"The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort.","volume":"20","author":"Brain","year":"2011","journal-title":"Psychooncology"},{"issue":"5","key":"jus190011r62","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cdp.2005.06.001","article-title":"Development of a risk assessment tool for women with a family history of breast cancer.","volume":"29","author":"Braithwaite","year":"2005","journal-title":"Cancer Detect Prev"},{"issue":"5","key":"jus190011r63","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(ISSN)1096-8628","article-title":"Genetic counseling for women with an intermediate family history of breast cancer.","volume":"90","author":"Burke","year":"2000","journal-title":"Am J Med Genet"},{"issue":"5","key":"jus190011r64","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/bjc.1998.135","article-title":"The use of videotaped information in cancer genetic counselling: a randomized evaluation study.","volume":"77","author":"Cull","year":"1998","journal-title":"Br J Cancer"},{"issue":"4","key":"jus190011r65","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/sj.bjc.6601170","article-title":"A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact.","volume":"89","author":"Fry","year":"2003","journal-title":"Br J Cancer"},{"issue":"5","key":"jus190011r66","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/archinte.165.5.523","article-title":"Patients\u2019 resistance to risk information in genetic counseling for BRCA1\/2.","volume":"165","author":"Gurmankin","year":"2005","journal-title":"Arch Intern Med"},{"issue":"1-3","key":"jus190011r67","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pec.2005.12.002","article-title":"Results of a randomized study of telephone versus in-person breast cancer risk counseling.","volume":"64","author":"Helmes","year":"2006","journal-title":"Patient Educ Couns"},{"issue":"5","key":"jus190011r68","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/(ISSN)1099-1611","article-title":"Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators.","volume":"7","author":"Hopwood","year":"1998","journal-title":"Psychooncology"},{"issue":"5","key":"jus190011r69","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/sj.bjc.6602081","article-title":"A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes.","volume":"91","author":"Hopwood","year":"2004","journal-title":"Br J Cancer"},{"issue":"1","key":"jus190011r70","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pec.2007.09.007","article-title":"Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1\/2 mutations.","volume":"70","author":"Kelly","year":"2008","journal-title":"Patient Educ Couns"},{"issue":"4, pt 2","key":"jus190011r71","first-page":"361","article-title":"Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.","volume":"8","author":"Lerman","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"jus190011r72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1037\/0278-6133.15.2.75","article-title":"A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style.","volume":"15","author":"Lerman","year":"1996","journal-title":"Health Psychol"},{"issue":"2","key":"jus190011r73","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/sj.bjc.6601502","article-title":"Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes.","volume":"90","author":"Lobb","year":"2004","journal-title":"Br J Cancer"},{"issue":"7","key":"jus190011r74","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1089\/jwh.2006.15.843","article-title":"Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.","volume":"15","author":"Matloff","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"issue":"6","key":"jus190011r75","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cdp.2007.10.013","article-title":"Risk perception among women receiving genetic counseling: a population-based follow-up study.","volume":"31","author":"Mikkelsen","year":"2007","journal-title":"Cancer Detect Prev"},{"issue":"1","key":"jus190011r76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/tbj.2009.15.issue-1","article-title":"Psychosocial consequences of genetic counseling: a population-based follow-up study.","volume":"15","author":"Mikkelsen","year":"2009","journal-title":"Breast J"},{"issue":"3","key":"jus190011r77","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.pec.2011.01.017","article-title":"Longer-term influence of breast cancer genetic counseling on cognitions and distress: smaller benefits for affected versus unaffected women.","volume":"85","author":"Pieterse","year":"2011","journal-title":"Patient Educ Couns"},{"issue":"7","key":"jus190011r78","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/02841860903104137","article-title":"Does enhanced information at cancer genetic counseling improve counselees\u2019 knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?\u2014a randomized study.","volume":"48","author":"Roshanai","year":"2009","journal-title":"Acta Oncol"},{"issue":"3","key":"jus190011r79","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10897-008-9210-z","article-title":"A systematic review of the impact of genetic counseling on risk perception accuracy.","volume":"18","author":"Smerecnik","year":"2009","journal-title":"J Genet Couns"},{"issue":"9","key":"jus190011r80","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/jmg.35.9.731","article-title":"Family history of breast cancer: what do women understand and recall about their genetic risk?","volume":"35","author":"Watson","year":"1998","journal-title":"J Med Genet"},{"issue":"5-6","key":"jus190011r81","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/sj.bjc.6690139","article-title":"The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.","volume":"79","author":"Watson","year":"1999","journal-title":"Br J Cancer"},{"issue":"3","key":"jus190011r82","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1089\/gte.2004.8.240","article-title":"Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study.","volume":"8","author":"Andrews","year":"2004","journal-title":"Genet Test"},{"issue":"2","key":"jus190011r83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1023\/B:FAME.0000039863.89137.f9","article-title":"Evaluation of psychosocial effects of pre-symptomatic testing for breast\/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.","volume":"3","author":"Arver","year":"2004","journal-title":"Fam Cancer"},{"issue":"2","key":"jus190011r84","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ypmed.2008.11.007","article-title":"Quality of life in asymptomatic BRCA1\/2 mutation carriers.","volume":"48","author":"Dagan","year":"2009","journal-title":"Prev Med"},{"issue":"3","key":"jus190011r85","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/gtmb.2008.0126","article-title":"Identification of patients at high risk of psychological distress after BRCA1 genetic testing.","volume":"13","author":"Ertmanski","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"issue":"5","key":"jus190011r86","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/sj.bjc.6603610","article-title":"Predictive genetic testing for BRCA1\/2 in a UK clinical cohort: three-year follow-up.","volume":"96","author":"Foster","year":"2007","journal-title":"Br J Cancer"},{"issue":"1","key":"jus190011r87","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/(ISSN)1099-1611","article-title":"The relationship between coping strategies and anxiety in women from families with familial breast-ovarian cancer in the absence of demonstrated mutations.","volume":"17","author":"Geirdal","year":"2008","journal-title":"Psychooncology"},{"issue":"2","key":"jus190011r88","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10689-004-7995-y","article-title":"Psychological distress in women at risk of hereditary breast\/ovarian or HNPCC cancers in the absence of demonstrated mutations.","volume":"4","author":"Geirdal","year":"2005","journal-title":"Fam Cancer"},{"issue":"1","key":"jus190011r89","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/gte.2006.9998","article-title":"Factors associated with an individual\u2019s decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling.","volume":"11","author":"Godard","year":"2007","journal-title":"Genet Test"},{"issue":"3","key":"jus190011r90","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1158\/1055-9965.EPI-11-0991","article-title":"Long-term psychosocial outcomes of BRCA1\/BRCA2 testing: differences across affected status and risk-reducing surgery choice.","volume":"21","author":"Graves","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"jus190011r91","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ejhg.2010.241","article-title":"Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1\/2 mutations.","volume":"19","author":"Julian-Reynier","year":"2011","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"jus190011r92","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/(ISSN)1097-0142","article-title":"The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation.","volume":"104","author":"Kinney","year":"2005","journal-title":"Cancer"},{"issue":"7","key":"jus190011r93","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/gim.2016.182","article-title":"Population screening for BRCA1\/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.","volume":"19","author":"Lieberman","year":"2017","journal-title":"Genet Med"},{"issue":"1","key":"jus190011r94","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12160-007-9004-9","article-title":"Benefit finding in response to BRCA1\/2 testing.","volume":"35","author":"Low","year":"2008","journal-title":"Ann Behav Med"},{"issue":"5","key":"jus190011r95","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s10897-017-0090-y","article-title":"Impact of panel gene testing for hereditary breast and ovarian cancer on patients.","volume":"26","author":"Lumish","year":"2017","journal-title":"J Genet Couns"},{"issue":"1","key":"jus190011r96","first-page":"379","article-title":"Population testing for cancer predisposing BRCA1\/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.","volume":"107","author":"Manchanda","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"jus190011r97","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/S0959-8049(02)00264-2","article-title":"Psychological impact of genetic testing in women from high-risk breast cancer families.","volume":"38","author":"Meiser","year":"2002","journal-title":"Eur J Cancer"},{"issue":"2","key":"jus190011r98","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10549-011-1941-0","article-title":"Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.","volume":"133","author":"Metcalfe","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"jus190011r99","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1023\/B:FAME.0000026820.32469.4a","article-title":"BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample.","volume":"3","author":"Reichelt","year":"2004","journal-title":"Fam Cancer"},{"issue":"3","key":"jus190011r100","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10689-008-9182-z","article-title":"Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast\/ovarian cancer.","volume":"7","author":"Reichelt","year":"2008","journal-title":"Fam Cancer"},{"issue":"2","key":"jus190011r101","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/jsr.2010.19.issue-2","article-title":"Sleep disturbances in asymptomatic BRCA1\/2 mutation carriers: women at high risk for breast-ovarian cancer.","volume":"19","author":"Shochat","year":"2010","journal-title":"J Sleep Res"},{"issue":"4, pt 2","key":"jus190011r102","first-page":"385","article-title":"Familial context of genetic testing for cancer susceptibility: moderating effect of siblings\u2019 test results on psychological distress one to two weeks after BRCA1 mutation testing.","volume":"8","author":"Smith","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"22","key":"jus190011r103","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1200\/JCO.2005.03.7259","article-title":"Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.","volume":"24","author":"van Dijk","year":"2006","journal-title":"J Clin Oncol"},{"issue":"20","key":"jus190011r104","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1200\/JCO.2003.10.100","article-title":"Long-term psychological impact of carrying a BRCA1\/2 mutation and prophylactic surgery: a 5-year follow-up study.","volume":"21","author":"van Oostrom","year":"2003","journal-title":"J Clin Oncol"},{"issue":"9","key":"jus190011r105","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"jus190011r106","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jmg.2008.062232","article-title":"Risk reducing mastectomy: outcomes in 10 European centres.","volume":"46","author":"Evans","year":"2009","journal-title":"J Med Genet"},{"issue":"1","key":"jus190011r107","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/tbj.12521","article-title":"Surgical decision making in the BRCA-positive population: institutional experience and comparison with recent literature.","volume":"22","author":"Flippo-Morton","year":"2016","journal-title":"Breast J"},{"issue":"2","key":"jus190011r108","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.","volume":"340","author":"Hartmann","year":"1999","journal-title":"N Engl J Med"},{"issue":"21","key":"jus190011r109","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","article-title":"Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.","volume":"93","author":"Hartmann","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"jus190011r110","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/annonc\/mdt134","article-title":"Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.","volume":"24","author":"Heemskerk-Gerritsen","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"jus190011r111","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv033","article-title":"Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction.","volume":"107","author":"Heemskerk-Gerritsen","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"jus190011r112","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw177","article-title":"Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers.","volume":"109","author":"Kotsopoulos","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"34","key":"jus190011r113","doi-asserted-by":"publisher","first-page":"8629","DOI":"10.1200\/JCO.2005.02.9199","article-title":"Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.","volume":"23","author":"Kramer","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11","key":"jus190011r114","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"jus190011r115","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cdp.2004.03.003","article-title":"Bilateral oophorectomy and breast cancer risk reduction among women with a family history.","volume":"28","author":"Olson","year":"2004","journal-title":"Cancer Detect Prev"},{"issue":"21","key":"jus190011r116","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"jus190011r117","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10549-009-0475-1","article-title":"Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.","volume":"118","author":"Shah","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"jus190011r118","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/cge.2011.79.issue-5","article-title":"Breast cancer after bilateral risk-reducing mastectomy.","volume":"79","author":"Skytte","year":"2011","journal-title":"Clin Genet"},{"issue":"17","key":"jus190011r119","first-page":"33","article-title":"Prophylactic oophorectomy in inherited breast\/ovarian cancer families.","author":"Struewing","year":"1995","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"5","key":"jus190011r120","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00238-015-1086-1","article-title":"Multidisciplinary management of risk-reducing mastectomy and immediate reconstruction: treatment algorithm and patient satisfaction.","volume":"38","author":"Alamouti","year":"2015","journal-title":"Eur J Plast Surg"},{"issue":"6","key":"jus190011r121","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/SLA.0b013e318214b55a","article-title":"Bilateral prophylactic mastectomy in Swedish women at high risk of breast cancer: a national survey.","volume":"253","author":"Arver","year":"2011","journal-title":"Ann Surg"},{"issue":"1","key":"jus190011r122","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/cge.2014.85.issue-1","article-title":"The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers.","volume":"85","author":"Borreani","year":"2014","journal-title":"Clin Genet"},{"issue":"6884","key":"jus190011r123","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/bmj.306.6884.1025","article-title":"Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.","volume":"306","author":"Bourne","year":"1993","journal-title":"BMJ"},{"issue":"1","key":"jus190011r124","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejso.2011.10.010","article-title":"Less correspondence between expectations before and cosmetic results after risk-reducing mastectomy in women who are mutation carriers: a prospective study.","volume":"38","author":"Brandberg","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"24","key":"jus190011r125","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1200\/JCO.2007.13.9568","article-title":"Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.","volume":"26","author":"Brandberg","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"jus190011r126","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejca.2006.09.009","article-title":"The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and\/or salpingo-oophorectomy.","volume":"43","author":"Bresser","year":"2007","journal-title":"Eur J Cancer"},{"issue":"9","key":"jus190011r127","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.ejca.2011.10.020","article-title":"Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study.","volume":"48","author":"den Heijer","year":"2012","journal-title":"Eur J Cancer"},{"issue":"3","key":"jus190011r128","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/pon.v22.3","article-title":"Long-term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile.","volume":"22","author":"den Heijer","year":"2013","journal-title":"Psychooncology"},{"issue":"1","key":"jus190011r129","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"6","key":"jus190011r130","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.breast.2010.05.003","article-title":"Bilateral prophylactic mastectomy in women with inherited risk of breast cancer\u2014prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery.","volume":"19","author":"Gahm","year":"2010","journal-title":"Breast"},{"issue":"3","key":"jus190011r131","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10689-012-9588-5","article-title":"Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer.","volume":"12","author":"Gopie","year":"2013","journal-title":"Fam Cancer"},{"issue":"12","key":"jus190011r132","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1245\/s10434-007-9449-x","article-title":"Prophylactic mastectomy in BRCA1\/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.","volume":"14","author":"Heemskerk-Gerritsen","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"jus190011r133","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":"No efficacy of annual gynaecological screening in BRCA1\/2 mutation carriers; an observational follow-up study.","volume":"96","author":"Hermsen","year":"2007","journal-title":"Br J Cancer"},{"issue":"10","key":"jus190011r134","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.bjps.2007.08.006","article-title":"Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.","volume":"61","author":"Isern","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"3","key":"jus190011r135","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.maturitas.2010.03.018","article-title":"Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers.","volume":"66","author":"Kenkhuis","year":"2010","journal-title":"Maturitas"},{"issue":"5","key":"jus190011r136","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa031759","article-title":"Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.","volume":"351","author":"Kriege","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"jus190011r137","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1002\/cncr.v106:11","article-title":"Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.","volume":"106","author":"Kriege","year":"2006","journal-title":"Cancer"},{"issue":"9473","key":"jus190011r138","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","article-title":"Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).","volume":"365","author":"Leach","year":"2005","journal-title":"Lancet"},{"issue":"17","key":"jus190011r139","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1002\/cncr.v117.17","article-title":"Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.","volume":"117","author":"Le-Petross","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"jus190011r140","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/(ISSN)1099-1611","article-title":"Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.","volume":"13","author":"Metcalfe","year":"2004","journal-title":"Psychooncology"},{"issue":"6","key":"jus190011r141","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/IGC.0b013e3181a83cd5","article-title":"Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer.","volume":"19","author":"Michelsen","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"jus190011r142","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.amjsurg.2017.06.017","article-title":"Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers.","volume":"214","author":"Nurudeen","year":"2017","journal-title":"Am J Surg"},{"issue":"7","key":"jus190011r143","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1037\/hea0000156","article-title":"Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1\/2 carriers.","volume":"34","author":"Portnoy","year":"2015","journal-title":"Health Psychol"},{"issue":"1","key":"jus190011r144","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/sj.bjc.6601912","article-title":"Impact of screening for breast cancer in high-risk women on health-related quality of life.","volume":"91","author":"Rijnsburger","year":"2004","journal-title":"Br J Cancer"},{"issue":"5","key":"jus190011r145","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.breast.2011.04.004","article-title":"Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance.","volume":"20","author":"Spiegel","year":"2011","journal-title":"Breast"},{"issue":"4","key":"jus190011r146","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1006\/pmed.1995.1066","article-title":"Predictors of and satisfaction with bilateral prophylactic mastectomy.","volume":"24","author":"Stefanek","year":"1995","journal-title":"Prev Med"},{"issue":"4","key":"jus190011r147","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/ecc.2011.20.issue-4","article-title":"High satisfaction rate ten years after bilateral prophylactic mastectomy\u2014a longitudinal study.","volume":"20","author":"Wasteson","year":"2011","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"2","key":"jus190011r148","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1148\/radiol.2017170458","article-title":"Influence of risk category and screening round on the performance of an MR imaging and mammography screening program in carriers of the BRCA mutation and other women at increased risk.","volume":"286","author":"Vreemann","year":"2018","journal-title":"Radiology"},{"issue":"36","key":"jus190011r149","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","article-title":"BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.","volume":"28","author":"Rijnsburger","year":"2010","journal-title":"J Clin Oncol"},{"issue":"22","key":"jus190011r151","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.","volume":"97","author":"Fisher","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"jus190011r152","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jnci\/djk050","article-title":"Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.","volume":"99","author":"Powles","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"jus190011r153","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/jnci\/djk154","article-title":"Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.","volume":"99","author":"Veronesi","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"jus190011r154","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/jnci\/djk049","article-title":"Long-term results of tamoxifen prophylaxis for breast cancer\u201496-month follow-up of the randomized IBIS-I trial.","volume":"99","author":"Cuzick","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"jus190011r155","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/jnci\/djn153","article-title":"Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk.","volume":"100","author":"Grady","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"jus190011r156","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1158\/1078-0432.CCR-06-0688","article-title":"Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk.","volume":"12","author":"Lippman","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"9922","key":"jus190011r157","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"issue":"13","key":"jus190011r158","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S1470-2045(14)71035-6","article-title":"Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial","volume":"15","author":"Sestak","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2","key":"jus190011r159","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.2015.63.4972","article-title":"Anastrozole-induced carpal tunnel syndrome: results from the International Breast Cancer Intervention Study II prevention trial.","volume":"34","author":"Spagnolo","year":"2016","journal-title":"J Clin Oncol"},{"issue":"25","key":"jus190011r160","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women.","volume":"364","author":"Goss","year":"2011","journal-title":"N Engl J Med"},{"issue":"14","key":"jus190011r161","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1200\/JCO.2013.51.2483","article-title":"Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.","volume":"32","author":"Maunsell","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"jus190011r162","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","article-title":"Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: preventing breast cancer.","volume":"3","author":"Vogel","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"jus190011r29","volume-title":"Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to update the U.S. Preventive Services Task Force Recommendation","author":"Nelson","year":"2013"},{"key":"jus190011r35","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.8430","volume-title":"Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation","author":"Nelson","year":"2019"},{"key":"jus190011r150","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.5780","volume-title":"Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the U.S. Preventive Services Task Force","author":"Nelson","year":"2019"},{"key":"jus190011r24","unstructured":"National Comprehensive Cancer Network (NCCN). Genetic\/familial high-risk assessment: breast and ovarian. NCCN website. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf. Published 2019. Accessed April 16, 2019."},{"key":"jus190011r26","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: breast cancer screening and diagnosis. NCCN website. https:\/\/www.nccn.org. Published 2018. Accessed May 1, 2019."},{"key":"jus190011r27","unstructured":"American College of Surgeons (ACS). Cancer Program Standards 2016. ACS website. https:\/\/www.facs.org\/cancer\/coc\/programstandards2012.html. Published 2016. Accessed May 1, 2019."},{"key":"jus190011r31","unstructured":"National Cancer Institute. PDQ\u00ae Breast Cancer Treatment. 2013. https:\/\/www.cancer.gov\/cancertopics\/pdq\/treatment\/breast\/healthprofessional. Accessed May 1, 2019."},{"key":"jus190011r36","unstructured":"US Preventive Services Task Force (USPSTF). Methods and Processes. USPSTF website. https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Name\/methods-and-processes. Published 2018. Accessed May 1, 2019."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/article-pdf\/322\/7\/666\/17807974\/jama_nelson_2019_us_190011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T07:07:29Z","timestamp":1721632049000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2748514"}},"subtitle":["Updated Evidence Report and Systematic Review for the US Preventive Services Task Force"],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":162,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,8,20]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.8430","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,20]]}}}